1st Quarter - Report

CAPITOL DECISIONS, INC. for ALKERMES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.1, Full-Year Continuing Appropriations Act, FY2011, Issues regarding access to Pharmacotherapies for addicition. Add to #17 below:National Institute of Drug Abuse (NIDA)

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: H.R. 1 (112th)

Alcohol and Drug Abuse ALC

Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 Mental health and addiction parity. Add to #17 below: National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity. Access and reimbursement issues regarding alcohol pharmacotherapies.

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 Mental health and addiction parity. Add to #17 below: National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity. Access and reimbursement issues regarding alcohol and opioid pharmacotherapies.

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.